Login
- Title:
A phase II study of the VEGFR- and FGFR-inhibitior Dovitinib (TKI258) in patients with refractory advanced or metastatic renal cell cancer previously treated with VEGFR- or mTOR-targeted therapy
- Document type:
- Meeting Abstract
- Author(s):
- Grunwald, V; Retz, M; Fenner, M; Wang, Y; Chang, J; Kay, A; Zuern, C; Gschwend, J
- Journal title abbreviation:
- Onkologie
- Year:
- 2011
- Journal volume:
- 34 6
- Pages contribution:
- 11-11
- Language:
- eng
- Print-ISSN:
- 0378-584X
- TUM Institution:
- Urologische Klinik und Poliklinik
BibTeX